BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Leukemia AND JUN, P05412, 3725, ENSG00000177606, AP1, c-Jun AND Treatment
505 results:

  • 1. On the mechanism of wogonin against acute monocytic leukemia using network pharmacology and experimental validation.
    Wang X; Wang Y; Chen J; Wang Q; Liu Z; Yin Y; Yang T; Shen T; Sa Y
    Sci Rep; 2024 May; 14(1):10114. PubMed ID: 38698063
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Azacitidine-Hesperetin Combination Induces S-phase Cell Cycle Arrest and Apoptosis in Human leukemia Cells.
    Lai KM; Tseng RH; Shih YH; Huang YC
    Anticancer Res; 2024 Mar; 44(3):1033-1044. PubMed ID: 38423637
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Paired single-B-cell transcriptomics and receptor sequencing reveal activation states and clonal signatures that characterize B cells in acute myeloid leukemia.
    Guo S; Mohan GS; Wang B; Li T; Daver N; Zhao Y; Reville PK; Hao D; Abbas HA
    J Immunother Cancer; 2024 Feb; 12(2):. PubMed ID: 38418394
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Roles of Glutathione and AP-1 in the Enhancement of Vitamin D-Induced Differentiation by Activators of the Nrf2 Signaling Pathway in Acute Myeloid leukemia Cells.
    Jramne-Saleem Y; Danilenko M
    Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396960
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Bioactive triterpenoid compounds of Poria cocos (Schw.) Wolf in the treatment of diabetic ulcers via regulating the PI3K-AKT signaling pathway.
    Ding X; Li S; Huang H; Shen J; Ding Y; Chen T; Ma L; Liu J; Lai Y; Chen B; Wang Y; Tan Q
    J Ethnopharmacol; 2024 May; 325():117812. PubMed ID: 38301984
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Cooperation of MLL1 and jun in controlling H3K4me3 on enhancers in colorectal cancer.
    Lin X; Chen JD; Wang CY; Cai Z; Zhan R; Yang C; Zhang LY; Li LY; Xiao Y; Chen MK; Wu M
    Genome Biol; 2023 Nov; 24(1):268. PubMed ID: 38012744
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Illuminating (HTLV-1)-induced adult T-cell leukemia/lymphoma transcriptomic signature: A systems virology approach.
    Forghani-Ramandi MM; Mostafavi B; Bahavar A; Dehghankar M; Siami Z; Mozhgani SH
    Virus Res; 2023 Dec; 338():199237. PubMed ID: 37832654
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Analysis of single-cell sequencing results of an elderly patient with myeloid leukemia reveals high expression of multiple oncogenes in monocytes and hematopoietic stem cells.
    Xu X; Xiong M; Ye H; Qi Y; Zhao Y
    Hematology; 2023 Dec; 28(1):2240129. PubMed ID: 37535066
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Heat shock factor 1 is a promising therapeutic target against adult T-cell leukemia.
    Ishikawa C; Mori N
    Med Oncol; 2023 May; 40(6):172. PubMed ID: 37165174
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Effect of the Mitogen-Activated Protein Kinase Pathway on the Erastin-Induced Ferroptosis of Molt-4 Cells.
    Liu N; Liu G; Jiang H; Yu J; Jin Y; Wang H
    DNA Cell Biol; 2023 Jun; 42(6):348-356. PubMed ID: 37140570
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Dimethyl Fumarate Suppresses the Proliferation of HTLV-1-infected T Cells by Inhibiting CBM Complex-triggered NF-B Signaling.
    Sato T; Maeta T; Ito S
    Anticancer Res; 2023 May; 43(5):1901-1908. PubMed ID: 37097671
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Heme oxygenase-1 inhibits the cytotoxicity of natural killer cells to acute myeloid leukemia by downregulating human leukocyte antigen-C.
    Feng C; Zhang T; Pan C; Kang Q; Wang L; Liu X; Shang Q; Chen S; Hu T; Wang J
    Cytotherapy; 2023 Jul; 25(7):728-738. PubMed ID: 36890092
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. JAK-STAT inhibition reduces endothelial prothrombotic activation and leukocyte-endothelial proadhesive interactions.
    Beckman JD; DaSilva A; Aronovich E; Nguyen A; Nguyen J; Hargis G; Reynolds D; Vercellotti GM; Betts B; Wood DK
    J Thromb Haemost; 2023 May; 21(5):1366-1380. PubMed ID: 36738826
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. mTOR inhibition amplifies the anti-lymphoma effect of PI3Kβ/δ blockage in diffuse large B-cell lymphoma.
    Xu W; Berning P; Erdmann T; Grau M; Bettazová N; Zapukhlyak M; Frontzek F; Kosnopfel C; Lenz P; Grondine M; Willis B; Lynch JT; Klener P; Hailfinger S; Barry ST; Lenz G
    Leukemia; 2023 Jan; 37(1):178-189. PubMed ID: 36352190
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Hypoxia-inducible factor 1α inhibitor induces cell death via suppression of BCR-ABL1 and Met expression in BCR-ABL1 tyrosine kinase inhibitor sensitive and resistant chronic myeloid leukemia cells.
    Tsubaki M; Takeda T; Matsuda T; Kimura A; Tanaka R; Nagayoshi S; Hoshida T; Tanabe K; Nishida S
    BMB Rep; 2023 Feb; 56(2):78-83. PubMed ID: 36195570
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Epigenomic profiling of glucocorticoid responses identifies cis-regulatory disruptions impacting steroid resistance in childhood acute lymphoblastic leukemia.
    Bergeron BP; Diedrich JD; Zhang Y; Barnett KR; Dong Q; Ferguson DC; Autry RJ; Yang W; Hansen BS; Smith C; Crews KR; Fan Y; Pui CH; Pruett-Miller SM; Relling MV; Yang JJ; Li C; Evans WE; Savic D
    Leukemia; 2022 Oct; 36(10):2374-2383. PubMed ID: 36028659
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Targeting autophagy increases the efficacy of proteasome inhibitor treatment in multiple myeloma by induction of apoptosis and activation of JNK.
    Salimi A; Schroeder KM; Schemionek-Reinders M; Vieri M; Maletzke S; Gezer D; Masouleh BK; Appelmann I
    BMC Cancer; 2022 Jul; 22(1):735. PubMed ID: 35790913
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. TGF-β signaling in myeloproliferative neoplasms contributes to myelofibrosis without disrupting the hematopoietic niche.
    Yao JC; Oetjen KA; Wang T; Xu H; Abou-Ezzi G; Krambs JR; Uttarwar S; Duncavage EJ; Link DC
    J Clin Invest; 2022 Jun; 132(11):. PubMed ID: 35439167
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. FLI1 regulates inflammation-associated genes to accelerate leukemogenesis.
    Chen B; Sheng D; Wang C; Liu W; Hu A; Xiao X; Gajendran B; Gao J; Hu J; Sample KM; Zacksenhaus E; Ben-David Y
    Cell Signal; 2022 Apr; 92():110269. PubMed ID: 35104574
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Improving the ability of CAR-T cells to hit solid tumors: Challenges and strategies.
    Zhang ZZ; Wang T; Wang XF; Zhang YQ; Song SX; Ma CQ
    Pharmacol Res; 2022 Jan; 175():106036. PubMed ID: 34920118
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 26.